Skip to main content
Premium Trial:

Request an Annual Quote

AlphaGene, Wayne State Partner to Study Brain Tumors

NEW YORK, Sept 11 – AlphaGene of Woburn, Mass., said Tuesday it has signed an agreement with Wayne State University to study malignant brain tumor cell types using gene expression technology.

Under the terms of the deal, AlphaGene will contribute its expertise in functional genomics, while Wayne State University will provide its research capabilities. Financial terms of the deal were not disclosed.

AlphaGene and Wayne State will also look to correlate gene expression patterns with treatment regimens and aim to develop new diagnostic and prognostic methods.

"We believe that by combining our technologies and expertise, we will gain a better insight into the genetic causes of the disease, and in so doing, we will identify new validated drug targets and markers for these difficult to treat brain tumors,” Donald McCarren, president and CEO of AlphaGene, said in a statement.

Wayne State University is currently developing a bank of brain tumors and normal blood specimens from consenting patients.

AlphaGene is a biotechnology company conducting research relating to neuro-degenerative diseases and cancer.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.